Artiodactyls
ARTIODACTYL - UNGULATES
Recommendations
- MGA implant (F)
- MGA in feed (F)
(a) for bovids, cervids and camelids less than 800 lb: 0.5 mg/day/animal
(b) for bovids, cervids and camelids 800 lb or more: 1.0 mg/day/animal
(c) for giraffes and Nile hippos: 2.0-3.0 mg/day/animal - MGA liquid (F) Daily doses as for MGA feed above
- PZP vaccine (F) Short term: 2-3 consecutive years
- Depo-Provera® (F) injection
(a) Giraffe dose: 450 mg every 6 weeks; if estrus occurs, increase by increments of 100 mg;
(b) Nile hippopotamus dose: 800 mg every 6 weeks
NOTE: Establishing a correct dosage is hampered by unavailability of body weight measures for individual giraffe and hippos - GnRH Agonists (F) Gonadotropin Releasing Hormone Agonists are considered the safest reversible contraceptives, but dosages and duration of efficacy are not well established for all species; side effects are generally similar to those associated with gonadectomy, especially the potential for weight gain unless diet is controlled; they have not been effective in male artiodactyls
• Suprelorin® (deslorelin) Implants
• Lupron® Depot Injection
Cautions
- Synthetic progestins may cause endometritis, pyometra and hydrometra
- PZP may not be reversible after long-term use (>3 consecutive years)
- Pregnant artiodactyls contracepted with progestins may be especially susceptible to suppression of uterine contractions; progestins should only be administered to animals CONFIRMED not pregnant.
- Depo-Provera may be a particular problem in pregnant females, since length of efficacy is so variable (approximate range: 2-24 months)
- GnRH agonists are not effective in male bovids; effectiveness unknown for other artiodactyls
- MGA feed and MGA liquid not recommended for suids; dose required for efficacy associated with side-effects. The PZP Vaccine is not effective either, because it will not elicit an immune response in suids.
Research and Monitoring
- PZP with Freund’s Incomplete Adjuvant, modified
- Surveillance for deleterious effects
• Contraception Annual Survey
• Tissue Submission Form – Pathology
• Adverse Reactions Report
THE USE OF ANY CONTRACEPTIVE IN NON-DOMESTIC ANIMALS IS CONSIDERED EXPERIMENTAL
(M=MALE-DIRECTED, F=FEMALE-DIRECTED METHOD)









